

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95878324 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.80091292 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.80091292 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.80091292 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.80091292 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.80091292 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.80091292 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.21061028 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14204920 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08320478 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.05301696 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 4.01468409 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.95320302 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95320302 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.78847110 |
| 16 | response to peptidoglycan (GO:0032494) | 3.52683127 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.52122542 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.44200938 |
| 19 | protein localization to endosome (GO:0036010) | 3.25876580 |
| 20 | cell adhesion mediated by integrin (GO:0033627) | 3.24200066 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.24076200 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23720057 |
| 23 | hypotonic response (GO:0006971) | 3.23611226 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23420188 |
| 25 | response to host immune response (GO:0052572) | 3.23420188 |
| 26 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.22780494 |
| 27 | skin morphogenesis (GO:0043589) | 3.22343794 |
| 28 | response to host (GO:0075136) | 3.19546771 |
| 29 | response to host defenses (GO:0052200) | 3.19546771 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19546771 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17323664 |
| 32 | response to interferon-alpha (GO:0035455) | 3.08630492 |
| 33 | I-kappaB phosphorylation (GO:0007252) | 3.08623812 |
| 34 | response to type I interferon (GO:0034340) | 3.05868486 |
| 35 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01813033 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.01469130 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.01469130 |
| 38 | negative regulation of granulocyte differentiation (GO:0030853) | 2.98549924 |
| 39 | detection of external biotic stimulus (GO:0098581) | 2.97345650 |
| 40 | apoptotic cell clearance (GO:0043277) | 2.97023205 |
| 41 | positive regulation of interferon-beta production (GO:0032728) | 2.96634488 |
| 42 | negative regulation of fatty acid transport (GO:2000192) | 2.96136176 |
| 43 | cell-substrate junction assembly (GO:0007044) | 2.95543453 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93730715 |
| 45 | detection of other organism (GO:0098543) | 2.91439954 |
| 46 | hemidesmosome assembly (GO:0031581) | 2.89534725 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89028471 |
| 48 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.88835750 |
| 49 | neutrophil activation (GO:0042119) | 2.88070222 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87579717 |
| 51 | microglial cell activation (GO:0001774) | 2.87371859 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82040116 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 2.81730919 |
| 54 | basement membrane organization (GO:0071711) | 2.81330771 |
| 55 | positive regulation of receptor recycling (GO:0001921) | 2.80869436 |
| 56 | pinocytosis (GO:0006907) | 2.79019033 |
| 57 | leukocyte aggregation (GO:0070486) | 2.78289959 |
| 58 | granulocyte activation (GO:0036230) | 2.77989131 |
| 59 | regulation of B cell differentiation (GO:0045577) | 2.75537350 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 2.75209324 |
| 61 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.75098905 |
| 62 | detection of biotic stimulus (GO:0009595) | 2.72791090 |
| 63 | tolerance induction (GO:0002507) | 2.72403850 |
| 64 | embryonic process involved in female pregnancy (GO:0060136) | 2.71696500 |
| 65 | endodermal cell differentiation (GO:0035987) | 2.70814459 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 2.66224557 |
| 67 | cortical actin cytoskeleton organization (GO:0030866) | 2.65024256 |
| 68 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.64362837 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.63957893 |
| 70 | cellular extravasation (GO:0045123) | 2.62022788 |
| 71 | regulation of macrophage cytokine production (GO:0010935) | 2.61966812 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.61853977 |
| 73 | germinal center formation (GO:0002467) | 2.61609865 |
| 74 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61097663 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61071785 |
| 76 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60331184 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60311277 |
| 78 | macrophage activation (GO:0042116) | 2.60137061 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.59875848 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59875848 |
| 81 | regulation of integrin activation (GO:0033623) | 2.58940067 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57111504 |
| 83 | defense response to protozoan (GO:0042832) | 2.56779623 |
| 84 | collagen fibril organization (GO:0030199) | 2.54574644 |
| 85 | cellular response to interferon-alpha (GO:0035457) | 2.54079900 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53739514 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.53389795 |
| 88 | respiratory burst (GO:0045730) | 2.52212598 |
| 89 | membrane protein ectodomain proteolysis (GO:0006509) | 2.52090655 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.52025197 |
| 91 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.51595491 |
| 92 | barbed-end actin filament capping (GO:0051016) | 2.51177584 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.49595417 |
| 94 | B cell mediated immunity (GO:0019724) | 2.49566536 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48266343 |
| 96 | natural killer cell mediated immunity (GO:0002228) | 2.46952252 |
| 97 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46952252 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.46044725 |
| 99 | stress fiber assembly (GO:0043149) | 2.45357392 |
| 100 | iron ion import (GO:0097286) | 2.45054883 |
| 101 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43872413 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 2.43281791 |
| 103 | detection of bacterium (GO:0016045) | 2.42735072 |
| 104 | natural killer cell differentiation (GO:0001779) | 2.42701891 |
| 105 | negative regulation of B cell proliferation (GO:0030889) | 2.42670511 |
| 106 | adherens junction assembly (GO:0034333) | 2.42494475 |
| 107 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.42286345 |
| 108 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.41483703 |
| 109 | positive thymic T cell selection (GO:0045059) | 2.40918414 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.39806753 |
| 111 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.39804478 |
| 112 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.39586241 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.38280154 |
| 114 | response to protozoan (GO:0001562) | 2.37793086 |
| 115 | cortical cytoskeleton organization (GO:0030865) | 2.37113272 |
| 116 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36418509 |
| 117 | leukocyte cell-cell adhesion (GO:0007159) | 2.36362504 |
| 118 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34854314 |
| 119 | substrate-dependent cell migration (GO:0006929) | 2.34832837 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33963119 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.33366199 |
| 122 | negative regulation of viral genome replication (GO:0045071) | 2.32805439 |
| 123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32758159 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.32023158 |
| 125 | focal adhesion assembly (GO:0048041) | 2.31824898 |
| 126 | cell-substrate adherens junction assembly (GO:0007045) | 2.31824898 |
| 127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.31436236 |
| 128 | membrane raft organization (GO:0031579) | 2.31319137 |
| 129 | positive regulation of interleukin-12 production (GO:0032735) | 2.31256831 |
| 130 | negative regulation of anoikis (GO:2000811) | 2.31185891 |
| 131 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.30879787 |
| 132 | collagen metabolic process (GO:0032963) | 2.30361004 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.30235440 |
| 134 | cellular response to zinc ion (GO:0071294) | 2.30067359 |
| 135 | response to laminar fluid shear stress (GO:0034616) | 2.28851484 |
| 136 | T cell migration (GO:0072678) | 2.27699513 |
| 137 | cellular response to interferon-gamma (GO:0071346) | 2.27687536 |
| 138 | regulation of interleukin-12 production (GO:0032655) | 2.27513648 |
| 139 | response to fluid shear stress (GO:0034405) | 2.26939045 |
| 140 | wound healing, spreading of cells (GO:0044319) | 2.25694823 |
| 141 | positive regulation of mast cell activation (GO:0033005) | 2.25634197 |
| 142 | myeloid dendritic cell differentiation (GO:0043011) | 2.25441615 |
| 143 | positive regulation of extracellular matrix organization (GO:1903055) | 2.25307704 |
| 144 | regulation of mast cell activation (GO:0033003) | 2.24861596 |
| 145 | wound healing, spreading of epidermal cells (GO:0035313) | 2.24817992 |
| 146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.24630081 |
| 147 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.21875526 |
| 148 | chondrocyte development (GO:0002063) | 2.20780755 |
| 149 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.18841834 |
| 150 | COPI coating of Golgi vesicle (GO:0048205) | 2.18069009 |
| 151 | Golgi transport vesicle coating (GO:0048200) | 2.18069009 |
| 152 | collagen catabolic process (GO:0030574) | 2.18013478 |
| 153 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.17462314 |
| 154 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.16018559 |
| 155 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.15411382 |
| 156 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.15130984 |
| 157 | mannose metabolic process (GO:0006013) | 2.14700094 |
| 158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.13694800 |
| 159 | regulation of leukocyte degranulation (GO:0043300) | 2.13313572 |
| 160 | nuclear pore complex assembly (GO:0051292) | 2.13027267 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.12729234 |
| 162 | cellular response to ethanol (GO:0071361) | 2.10981195 |
| 163 | mesodermal cell differentiation (GO:0048333) | 2.10487830 |
| 164 | integrin-mediated signaling pathway (GO:0007229) | 2.10467602 |
| 165 | epithelial cell-cell adhesion (GO:0090136) | 2.10208809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.52872998 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.63100811 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.44058217 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.10164684 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62124686 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42986645 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41263239 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.40969786 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.40868971 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24679628 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23116153 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01570356 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86209124 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81687214 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73695776 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67330916 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.65909756 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57145083 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46372933 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39048990 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30713611 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12363861 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08908505 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06005443 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05056059 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03830939 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.98959598 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97238719 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94618658 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.94020381 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93064084 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.87821507 |
| 33 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82851450 |
| 34 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76936811 |
| 35 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.76815819 |
| 36 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75775259 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72235365 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.71913695 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65910155 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64333104 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60973044 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59152864 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59138129 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.57345540 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55876489 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54680448 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54586223 |
| 48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52869775 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52647344 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52489369 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50912612 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49812747 |
| 53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49527369 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45444320 |
| 55 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44166771 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42584649 |
| 57 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.40908935 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39749295 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39402422 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39254247 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39220945 |
| 62 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.36355013 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33701257 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32787022 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32421483 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32121185 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31549629 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31281705 |
| 69 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31072967 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29868513 |
| 71 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29356127 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29155331 |
| 73 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29155331 |
| 74 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26597600 |
| 75 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25741744 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25741744 |
| 77 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25522361 |
| 78 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24770878 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23501089 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22080752 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21408652 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19433988 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18371362 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17710300 |
| 85 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16787122 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16296812 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16182975 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15822046 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15698843 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13169981 |
| 91 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13002403 |
| 92 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12577983 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10913497 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10784200 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10131683 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09967871 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09709204 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09218874 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07672663 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06286397 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06222733 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05047895 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05022409 |
| 104 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04529368 |
| 105 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03393949 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02962690 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02105000 |
| 108 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01723472 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99695996 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97578136 |
| 111 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97286007 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96671986 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96671986 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96227738 |
| 115 | * MAF_26560356_Chip-Seq_TH2_Human | 0.96104906 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95426894 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93229159 |
| 118 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.92038817 |
| 119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89375194 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89149752 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84743041 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84021364 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83346061 |
| 124 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81794944 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81609514 |
| 126 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81465469 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80877314 |
| 128 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80207690 |
| 129 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79294171 |
| 130 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78980672 |
| 131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77863337 |
| 132 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.77269256 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76467853 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75862520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.58732635 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 2.88223593 |
| 3 | MP0000569_abnormal_digit_pigmentation | 2.68419595 |
| 4 | MP0003436_decreased_susceptibility_to | 2.68014759 |
| 5 | MP0000685_abnormal_immune_system | 2.54136442 |
| 6 | MP0003303_peritoneal_inflammation | 2.52274398 |
| 7 | MP0005387_immune_system_phenotype | 2.49444300 |
| 8 | MP0001790_abnormal_immune_system | 2.49444300 |
| 9 | MP0002419_abnormal_innate_immunity | 2.24621339 |
| 10 | MP0001800_abnormal_humoral_immune | 2.23111198 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.17222204 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.16286932 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.15740459 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.14921494 |
| 15 | MP0009278_abnormal_bone_marrow | 2.11848621 |
| 16 | MP0009785_altered_susceptibility_to | 2.11483571 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.06224249 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.01962008 |
| 19 | MP0004272_abnormal_basement_membrane | 1.99412209 |
| 20 | * MP0005025_abnormal_response_to | 1.97915284 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.93781742 |
| 22 | MP0005671_abnormal_response_to | 1.89598351 |
| 23 | MP0002006_tumorigenesis | 1.86952303 |
| 24 | MP0002723_abnormal_immune_serum | 1.85385426 |
| 25 | MP0003724_increased_susceptibility_to | 1.83172903 |
| 26 | MP0004510_myositis | 1.81051116 |
| 27 | MP0008260_abnormal_autophagy | 1.80603402 |
| 28 | MP0003279_aneurysm | 1.75462270 |
| 29 | * MP0001819_abnormal_immune_cell | 1.75085956 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 1.74476043 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.73161041 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.71917895 |
| 33 | MP0006082_CNS_inflammation | 1.69725125 |
| 34 | MP0005451_abnormal_body_composition | 1.69632644 |
| 35 | MP0004947_skin_inflammation | 1.67644071 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.66061508 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.64169329 |
| 38 | MP0001853_heart_inflammation | 1.63822040 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.62881988 |
| 40 | MP0002405_respiratory_system_inflammati | 1.61466995 |
| 41 | MP0001958_emphysema | 1.60749805 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.57914582 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.56597186 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.56597186 |
| 45 | MP0005275_abnormal_skin_tensile | 1.55084360 |
| 46 | MP0001849_ear_inflammation | 1.50419958 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.45011845 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.44616917 |
| 49 | MP0005023_abnormal_wound_healing | 1.42258090 |
| 50 | MP0005409_darkened_coat_color | 1.41956287 |
| 51 | MP0003448_altered_tumor_morphology | 1.41747634 |
| 52 | * MP0002398_abnormal_bone_marrow | 1.41199201 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.39451424 |
| 54 | * MP0000716_abnormal_immune_system | 1.37515352 |
| 55 | MP0002254_reproductive_system_inflammat | 1.37151002 |
| 56 | MP0005164_abnormal_response_to | 1.36241169 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.35742050 |
| 58 | MP0003091_abnormal_cell_migration | 1.34093002 |
| 59 | MP0004858_abnormal_nervous_system | 1.31280346 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.29412343 |
| 61 | * MP0000689_abnormal_spleen_morphology | 1.25919233 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.24337292 |
| 63 | MP0004883_abnormal_blood_vessel | 1.22641552 |
| 64 | MP0010307_abnormal_tumor_latency | 1.20587214 |
| 65 | MP0000858_altered_metastatic_potential | 1.19294881 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.18829681 |
| 67 | MP0000343_altered_response_to | 1.17371851 |
| 68 | MP0002722_abnormal_immune_system | 1.15876290 |
| 69 | * MP0000767_abnormal_smooth_muscle | 1.15491504 |
| 70 | MP0002933_joint_inflammation | 1.15420692 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.14848891 |
| 72 | MP0005390_skeleton_phenotype | 1.14427874 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.14236288 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.12735714 |
| 75 | * MP0002429_abnormal_blood_cell | 1.12266395 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.11625989 |
| 77 | MP0001873_stomach_inflammation | 1.10903960 |
| 78 | MP0006054_spinal_hemorrhage | 1.10767708 |
| 79 | MP0001915_intracranial_hemorrhage | 1.10136144 |
| 80 | MP0000733_abnormal_muscle_development | 1.09737040 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.09173170 |
| 82 | MP0005248_abnormal_Harderian_gland | 1.08808562 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.08096130 |
| 84 | MP0009764_decreased_sensitivity_to | 1.05798139 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.04191910 |
| 86 | * MP0008469_abnormal_protein_level | 1.01602292 |
| 87 | MP0009840_abnormal_foam_cell | 0.99924909 |
| 88 | MP0002060_abnormal_skin_morphology | 0.99434697 |
| 89 | MP0003045_fibrosis | 0.97313919 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.96263332 |
| 91 | MP0005621_abnormal_cell_physiology | 0.94344997 |
| 92 | MP0004233_abnormal_muscle_weight | 0.94273528 |
| 93 | MP0005503_abnormal_tendon_morphology | 0.92104408 |
| 94 | MP0003828_pulmonary_edema | 0.91008989 |
| 95 | MP0003690_abnormal_glial_cell | 0.90385992 |
| 96 | MP0002133_abnormal_respiratory_system | 0.89827884 |
| 97 | MP0005388_respiratory_system_phenotype | 0.89827884 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.88894842 |
| 99 | MP0001542_abnormal_bone_strength | 0.88507653 |
| 100 | MP0002796_impaired_skin_barrier | 0.87389423 |
| 101 | MP0008004_abnormal_stomach_pH | 0.87086031 |
| 102 | MP0000428_abnormal_craniofacial_morphol | 0.86966177 |
| 103 | MP0002168_other_aberrant_phenotype | 0.83943245 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.83538977 |
| 105 | MP0009763_increased_sensitivity_to | 0.82036793 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.81887902 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.81570118 |
| 108 | MP0009053_abnormal_anal_canal | 0.79510043 |
| 109 | MP0003075_altered_response_to | 0.78521879 |
| 110 | MP0003941_abnormal_skin_development | 0.78470787 |
| 111 | * MP0000371_diluted_coat_color | 0.78421851 |
| 112 | MP0001243_abnormal_dermal_layer | 0.77747785 |
| 113 | MP0002009_preneoplasia | 0.77501487 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.76741564 |
| 115 | MP0000490_abnormal_crypts_of | 0.75842795 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.74444830 |
| 117 | MP0000604_amyloidosis | 0.73855773 |
| 118 | MP0003795_abnormal_bone_structure | 0.73814625 |
| 119 | MP0000534_abnormal_ureter_morphology | 0.73752748 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.73453111 |
| 121 | MP0000249_abnormal_blood_vessel | 0.73249193 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.72617627 |
| 123 | MP0000383_abnormal_hair_follicle | 0.72577413 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.72226486 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.71771050 |
| 126 | MP0001851_eye_inflammation | 0.70195478 |
| 127 | MP0008007_abnormal_cellular_replicative | 0.68939391 |
| 128 | MP0002108_abnormal_muscle_morphology | 0.68025899 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.65823264 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.62908398 |
| 131 | MP0005166_decreased_susceptibility_to | 0.61609529 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.59677060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.38028947 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.25811226 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.06299530 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 3.30691323 |
| 5 | Arterial tortuosity (HP:0005116) | 3.27869895 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.26419604 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.22918606 |
| 8 | Vascular tortuosity (HP:0004948) | 3.18706464 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 3.18620084 |
| 10 | Myositis (HP:0100614) | 3.07297110 |
| 11 | Myocardial infarction (HP:0001658) | 3.06925742 |
| 12 | Atrophic scars (HP:0001075) | 2.88906060 |
| 13 | Cellulitis (HP:0100658) | 2.82258702 |
| 14 | Recurrent fungal infections (HP:0002841) | 2.80396765 |
| 15 | Hematochezia (HP:0002573) | 2.78843293 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76830381 |
| 17 | Orchitis (HP:0100796) | 2.76757289 |
| 18 | Cerebral aneurysm (HP:0004944) | 2.76574359 |
| 19 | Protrusio acetabuli (HP:0003179) | 2.74695159 |
| 20 | Gingivitis (HP:0000230) | 2.71956025 |
| 21 | Recurrent skin infections (HP:0001581) | 2.67508748 |
| 22 | Recurrent viral infections (HP:0004429) | 2.66248053 |
| 23 | Peritonitis (HP:0002586) | 2.64047871 |
| 24 | Shallow orbits (HP:0000586) | 2.59839918 |
| 25 | Broad face (HP:0000283) | 2.57291245 |
| 26 | Aortic aneurysm (HP:0004942) | 2.56709256 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.55261383 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.53262806 |
| 29 | Vasculitis (HP:0002633) | 2.49262581 |
| 30 | Short 4th metacarpal (HP:0010044) | 2.47291914 |
| 31 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.47291914 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.44260487 |
| 33 | Optic neuritis (HP:0100653) | 2.44260487 |
| 34 | Arterial thrombosis (HP:0004420) | 2.43273926 |
| 35 | Aortic dissection (HP:0002647) | 2.42341912 |
| 36 | Fragile skin (HP:0001030) | 2.42120711 |
| 37 | * Periodontitis (HP:0000704) | 2.41811291 |
| 38 | Glomerulonephritis (HP:0000099) | 2.39403588 |
| 39 | Ankle contracture (HP:0006466) | 2.36970788 |
| 40 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.33207326 |
| 41 | Aneurysm (HP:0002617) | 2.31941197 |
| 42 | Premature rupture of membranes (HP:0001788) | 2.31925303 |
| 43 | * Osteolytic defects of the hand bones (HP:0009699) | 2.31789849 |
| 44 | * Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31789849 |
| 45 | Increased density of long bones (HP:0006392) | 2.31051646 |
| 46 | Chronic otitis media (HP:0000389) | 2.30706626 |
| 47 | Mitral regurgitation (HP:0001653) | 2.30241238 |
| 48 | Spondylolisthesis (HP:0003302) | 2.29613864 |
| 49 | Gingival bleeding (HP:0000225) | 2.28798553 |
| 50 | Genu recurvatum (HP:0002816) | 2.26515114 |
| 51 | Blue sclerae (HP:0000592) | 2.25380573 |
| 52 | Thick nail (HP:0001805) | 2.23405042 |
| 53 | Nephritis (HP:0000123) | 2.22789257 |
| 54 | Colitis (HP:0002583) | 2.22614520 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19957925 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19957925 |
| 57 | Mitral valve prolapse (HP:0001634) | 2.17576815 |
| 58 | Bladder diverticulum (HP:0000015) | 2.17100453 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.16636098 |
| 60 | Thin bony cortex (HP:0002753) | 2.15055962 |
| 61 | Osteomyelitis (HP:0002754) | 2.14838799 |
| 62 | Dilatation of the ascending aorta (HP:0005111) | 2.14811882 |
| 63 | Increased connective tissue (HP:0009025) | 2.13950274 |
| 64 | Emphysema (HP:0002097) | 2.13756460 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.12471429 |
| 66 | Pustule (HP:0200039) | 2.12171761 |
| 67 | Obstructive lung disease (HP:0006536) | 2.11145112 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11145112 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.09805515 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.09546224 |
| 71 | Meningitis (HP:0001287) | 2.08595199 |
| 72 | * Wormian bones (HP:0002645) | 2.08518108 |
| 73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08456216 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08456216 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08456216 |
| 76 | Overgrowth (HP:0001548) | 2.08118661 |
| 77 | Urethral obstruction (HP:0000796) | 2.07624846 |
| 78 | Soft skin (HP:0000977) | 2.06083960 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.02007388 |
| 80 | Flat acetabular roof (HP:0003180) | 1.99807898 |
| 81 | Cervical subluxation (HP:0003308) | 1.99155820 |
| 82 | Inflammation of the large intestine (HP:0002037) | 1.99147584 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 1.97116352 |
| 84 | * Joint laxity (HP:0001388) | 1.96927751 |
| 85 | Abnormality of complement system (HP:0005339) | 1.96113958 |
| 86 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.95965283 |
| 87 | Aortic regurgitation (HP:0001659) | 1.93936146 |
| 88 | Prolonged bleeding time (HP:0003010) | 1.93803464 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93704320 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 1.93227341 |
| 91 | Neonatal short-limb short stature (HP:0008921) | 1.92098723 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90631435 |
| 93 | Camptodactyly of toe (HP:0001836) | 1.88945105 |
| 94 | Disproportionate tall stature (HP:0001519) | 1.88823054 |
| 95 | Increased variability in muscle fiber diameter (HP:0003557) | 1.88385725 |
| 96 | Prostate neoplasm (HP:0100787) | 1.88132535 |
| 97 | Broad metatarsal (HP:0001783) | 1.88113530 |
| 98 | Leukocytosis (HP:0001974) | 1.84368646 |
| 99 | IgM deficiency (HP:0002850) | 1.82339995 |
| 100 | Recurrent bronchitis (HP:0002837) | 1.82143465 |
| 101 | Amyloidosis (HP:0011034) | 1.81956698 |
| 102 | Ulnar bowing (HP:0003031) | 1.81909126 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 1.79979900 |
| 104 | Abnormality of oral frenula (HP:0000190) | 1.78971365 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 1.78847130 |
| 106 | Abnormal platelet volume (HP:0011876) | 1.78762245 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 1.78502741 |
| 108 | Abnormal ossification of hand bones (HP:0005921) | 1.77926011 |
| 109 | Abnormality of the 4th metacarpal (HP:0010012) | 1.77615353 |
| 110 | Hypoplasia of the iris (HP:0007676) | 1.77426934 |
| 111 | Epistaxis (HP:0000421) | 1.76936145 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 1.76911594 |
| 113 | Stomatitis (HP:0010280) | 1.76370789 |
| 114 | Joint contractures involving the joints of the feet (HP:0100492) | 1.76083782 |
| 115 | Flexion contracture of toe (HP:0005830) | 1.76083782 |
| 116 | * Vertebral compression fractures (HP:0002953) | 1.76028111 |
| 117 | Natal tooth (HP:0000695) | 1.75996921 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.74821071 |
| 119 | Vertebral arch anomaly (HP:0008438) | 1.74672588 |
| 120 | Narrow palate (HP:0000189) | 1.74603155 |
| 121 | * Absent frontal sinuses (HP:0002688) | 1.74463870 |
| 122 | Subacute progressive viral hepatitis (HP:0006572) | 1.74198400 |
| 123 | Persistence of primary teeth (HP:0006335) | 1.73703812 |
| 124 | Wide anterior fontanel (HP:0000260) | 1.73495682 |
| 125 | Hyperacusis (HP:0010780) | 1.73116701 |
| 126 | Abnormality of the acetabulum (HP:0003170) | 1.72715355 |
| 127 | Esophageal varix (HP:0002040) | 1.72043815 |
| 128 | Bruising susceptibility (HP:0000978) | 1.71767710 |
| 129 | Alopecia of scalp (HP:0002293) | 1.71515393 |
| 130 | Viral hepatitis (HP:0006562) | 1.71506959 |
| 131 | Spinal rigidity (HP:0003306) | 1.71156580 |
| 132 | IgA deficiency (HP:0002720) | 1.70861246 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.70753914 |
| 134 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70595465 |
| 135 | Dysostosis multiplex (HP:0000943) | 1.69228481 |
| 136 | Urticaria (HP:0001025) | 1.68608471 |
| 137 | Thoracolumbar scoliosis (HP:0002944) | 1.67801130 |
| 138 | Thrombocytosis (HP:0001894) | 1.67171298 |
| 139 | Hyperextensible skin (HP:0000974) | 1.66534008 |
| 140 | Increased mean platelet volume (HP:0011877) | 1.66489869 |
| 141 | Elbow flexion contracture (HP:0002987) | 1.65283990 |
| 142 | Complement deficiency (HP:0004431) | 1.65002190 |
| 143 | Tibial bowing (HP:0002982) | 1.64838992 |
| 144 | Follicular hyperkeratosis (HP:0007502) | 1.64503132 |
| 145 | Cupped ribs (HP:0000887) | 1.64157599 |
| 146 | Premature loss of primary teeth (HP:0006323) | 1.63914540 |
| 147 | Bicuspid aortic valve (HP:0001647) | 1.63487921 |
| 148 | Deep philtrum (HP:0002002) | 1.62494120 |
| 149 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62057128 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.60836027 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60836027 |
| 152 | Cerebral inclusion bodies (HP:0100314) | 1.60537673 |
| 153 | Loss of speech (HP:0002371) | 1.59402581 |
| 154 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.58588044 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.56719144 |
| 156 | Abnormality of dentin (HP:0010299) | 1.56507939 |
| 157 | Delayed cranial suture closure (HP:0000270) | 1.56347933 |
| 158 | Relative macrocephaly (HP:0004482) | 1.56051067 |
| 159 | Ankyloglossia (HP:0010296) | 1.55670969 |
| 160 | * Spinal cord lesions (HP:0100561) | 1.54877707 |
| 161 | * Syringomyelia (HP:0003396) | 1.54877707 |
| 162 | Short clavicles (HP:0000894) | 1.54567533 |
| 163 | Broad ribs (HP:0000885) | 1.53079368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.39704038 |
| 2 | MAP4K1 | 3.13410097 |
| 3 | PRPF4B | 2.81740399 |
| 4 | TYK2 | 2.77025361 |
| 5 | JAK3 | 2.33562931 |
| 6 | TBK1 | 2.15350583 |
| 7 | JAK1 | 2.14670323 |
| 8 | TTN | 2.11641339 |
| 9 | CDK12 | 2.09190139 |
| 10 | ERN1 | 2.07249559 |
| 11 | IRAK3 | 2.06421159 |
| 12 | TGFBR2 | 2.03243891 |
| 13 | IKBKE | 2.01890879 |
| 14 | KIT | 2.00670515 |
| 15 | IRAK4 | 1.94904028 |
| 16 | BLK | 1.91021529 |
| 17 | IKBKB | 1.90033641 |
| 18 | SIK1 | 1.87796154 |
| 19 | CAMK1D | 1.86792016 |
| 20 | ICK | 1.84230638 |
| 21 | NEK9 | 1.83990304 |
| 22 | STK10 | 1.79510950 |
| 23 | CHUK | 1.78264753 |
| 24 | CSF1R | 1.72380615 |
| 25 | TRIB3 | 1.72307267 |
| 26 | FGFR3 | 1.65923453 |
| 27 | MAP3K10 | 1.54334910 |
| 28 | FGFR4 | 1.50815748 |
| 29 | SMG1 | 1.46358779 |
| 30 | ZAP70 | 1.42267597 |
| 31 | TXK | 1.41501463 |
| 32 | CSK | 1.37479902 |
| 33 | BTK | 1.36804167 |
| 34 | RPS6KA4 | 1.34939836 |
| 35 | EPHB1 | 1.34315196 |
| 36 | PIM1 | 1.33704255 |
| 37 | MAP2K3 | 1.33056939 |
| 38 | RIPK4 | 1.31532099 |
| 39 | RIPK1 | 1.29119745 |
| 40 | KSR2 | 1.28877582 |
| 41 | PTK6 | 1.26888156 |
| 42 | MAP3K6 | 1.26630681 |
| 43 | EPHA3 | 1.25842425 |
| 44 | MAP3K13 | 1.24758759 |
| 45 | HCK | 1.22678472 |
| 46 | BMX | 1.18773808 |
| 47 | LRRK2 | 1.16981585 |
| 48 | MAP3K2 | 1.16680024 |
| 49 | CAMK1G | 1.16262474 |
| 50 | EEF2K | 1.16143195 |
| 51 | PKN2 | 1.16027618 |
| 52 | TRPM7 | 1.13198517 |
| 53 | CDK6 | 1.11973614 |
| 54 | PTK2 | 1.11561375 |
| 55 | MOS | 1.10082309 |
| 56 | CDC42BPA | 1.08029112 |
| 57 | LATS1 | 1.07900768 |
| 58 | MARK2 | 1.07560718 |
| 59 | STK38 | 1.06698430 |
| 60 | TEC | 1.05799028 |
| 61 | MELK | 1.00250330 |
| 62 | STK3 | 1.00210363 |
| 63 | MAPK7 | 0.98765007 |
| 64 | AKT3 | 0.97699430 |
| 65 | STK4 | 0.97111512 |
| 66 | MAP3K1 | 0.96544862 |
| 67 | TAOK3 | 0.95862377 |
| 68 | CLK1 | 0.95193066 |
| 69 | MATK | 0.94478418 |
| 70 | LATS2 | 0.94033390 |
| 71 | PRKD2 | 0.93885202 |
| 72 | SIK3 | 0.93563921 |
| 73 | BRD4 | 0.92546798 |
| 74 | SYK | 0.90383372 |
| 75 | PAK4 | 0.89991644 |
| 76 | RPS6KA2 | 0.85942573 |
| 77 | MET | 0.85709194 |
| 78 | TAOK2 | 0.85036232 |
| 79 | LCK | 0.84833874 |
| 80 | WNK1 | 0.83303448 |
| 81 | RET | 0.82746459 |
| 82 | JAK2 | 0.82527046 |
| 83 | LYN | 0.81620660 |
| 84 | SCYL2 | 0.74254115 |
| 85 | TAOK1 | 0.73366473 |
| 86 | MARK3 | 0.72423806 |
| 87 | NUAK1 | 0.70843242 |
| 88 | FLT3 | 0.70787530 |
| 89 | ITK | 0.69375548 |
| 90 | EIF2AK2 | 0.69299048 |
| 91 | MKNK1 | 0.69273949 |
| 92 | SGK3 | 0.68640761 |
| 93 | IRAK1 | 0.68467478 |
| 94 | MYLK | 0.68180808 |
| 95 | MAP3K7 | 0.66437573 |
| 96 | KSR1 | 0.65731610 |
| 97 | IRAK2 | 0.65486781 |
| 98 | PDGFRA | 0.63853412 |
| 99 | MST1R | 0.62994093 |
| 100 | PDPK1 | 0.62071787 |
| 101 | EPHA2 | 0.62049941 |
| 102 | CDK4 | 0.61456312 |
| 103 | ERBB3 | 0.60185369 |
| 104 | GRK6 | 0.59327653 |
| 105 | EPHB2 | 0.59254179 |
| 106 | MTOR | 0.59234650 |
| 107 | CDK9 | 0.59119373 |
| 108 | PDGFRB | 0.58775100 |
| 109 | MKNK2 | 0.56906951 |
| 110 | NEK6 | 0.56745541 |
| 111 | RPS6KA6 | 0.55188965 |
| 112 | ABL1 | 0.54982588 |
| 113 | MAP3K3 | 0.54531587 |
| 114 | SIK2 | 0.53169756 |
| 115 | FGR | 0.51773279 |
| 116 | RAF1 | 0.51130898 |
| 117 | BMPR2 | 0.50435017 |
| 118 | EGFR | 0.50267987 |
| 119 | PIM2 | 0.48734765 |
| 120 | ROCK2 | 0.46726107 |
| 121 | FES | 0.46368891 |
| 122 | NTRK1 | 0.45814521 |
| 123 | FER | 0.45804766 |
| 124 | MAPKAPK2 | 0.45350546 |
| 125 | ZAK | 0.44546709 |
| 126 | SGK2 | 0.43724062 |
| 127 | RPS6KL1 | 0.42850799 |
| 128 | RPS6KC1 | 0.42850799 |
| 129 | NLK | 0.40176446 |
| 130 | ATR | 0.38006147 |
| 131 | TGFBR1 | 0.33857813 |
| 132 | PAK2 | 0.33785900 |
| 133 | YES1 | 0.33155820 |
| 134 | INSR | 0.32470001 |
| 135 | PIK3CG | 0.32400427 |
| 136 | IGF1R | 0.32058605 |
| 137 | DDR2 | 0.31451786 |
| 138 | DMPK | 0.31361423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82798051 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75694564 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33675274 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19922206 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13125575 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.06393434 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.00191022 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.98993244 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96981938 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.77971779 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77602148 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74363767 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74123230 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.69883364 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69791828 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.67419684 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66855186 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66336748 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.57265383 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.54154333 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53167109 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51992912 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50408932 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48770910 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44907245 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44594976 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41425306 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40690884 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40035623 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39451164 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39290861 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39036024 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.36268505 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.32916293 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30547966 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29854642 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24258294 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.24179586 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23400293 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22425978 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22141825 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21507731 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.20113091 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20006482 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17732078 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17715900 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14964823 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12819906 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10717816 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.09353133 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.07748545 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.06442891 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05922869 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 1.05813633 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05534368 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03371204 |
| 57 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02528002 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01934845 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99968053 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.98851422 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.98213748 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.97914187 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95664881 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95548191 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95215975 |
| 66 | * Notch signaling pathway_Homo sapiens_hsa04330 | 0.94448697 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93332782 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.92636354 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92062245 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.89513308 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.88414206 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88275713 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85959636 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85414923 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85396674 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83533087 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81551361 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80712459 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80681584 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80164563 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79815900 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79195081 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78444322 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73434902 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73309113 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73077420 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.71694630 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71427789 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.70594282 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70578133 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68738460 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.68204252 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.65612902 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64495834 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.64237135 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64085509 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63677571 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63401323 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62064466 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59680599 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59303053 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59130684 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56704649 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55733362 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54977453 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54917962 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54891409 |
| 108 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54351769 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52648966 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52165160 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52024587 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51422949 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49978490 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.45977815 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44213914 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43835808 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41116310 |
| 118 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36692625 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.35410016 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34700063 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.34205495 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31765261 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30392246 |
| 124 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29759027 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29734043 |
| 126 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.29080492 |

